[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100579122":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":30,"locations":36,"responsibleParty":55,"collaborators":23,"id":58,"slug":23,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":23,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":23,"enrollmentInfo":66,"targetDuration":23,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":23,"overallStatus":38,"whyStopped":23,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"MTP group","EXPERIMENTAL","Patients will receive multiple mid-transverse process to pleura (MTP) block after induction of anesthesia.",[13],"Other: Multiple Mid-Transverse Process to Pleura (MTP) Block",{"label":15,"type":10,"description":16,"interventionNames":17},"PCA group","Patients will receive IV-PCA. Morphine is generally administered as an initial loading dose of 0.05-0.1 mg\u002Fkg before the end of surgery, with PCA settings of a bolus dose of 0.01-0.03 mg\u002Fkg, a lockout interval of 6-10 min, and a background infusion of 0.01-0.02 mg\u002Fkg\u002Fh.",[18],"Drug: Morphine",[20,24],{"type":6,"name":21,"description":11,"armGroupLabels":22,"otherNames":23},"Multiple Mid-Transverse Process to Pleura (MTP) Block",[9],null,{"type":25,"name":26,"description":16,"armGroupLabels":27,"otherNames":28},"DRUG","Morphine",[15],[29],"PCA",[31],{"name":32,"role":33,"phone":34,"phoneExt":23,"email":35},"Mohammed S Elsharkawy, MD","CONTACT","00201148207870","mselsharkawy@med.tanta.edu.eg",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Tanta","El-Gharbia","31527","Egypt","EG",{"type":45,"coordinates":46},"Point",[47,48],31.00192,30.78847,{"lat":48,"lon":47},[51,52],{"name":32,"role":33,"phone":34,"phoneExt":23,"email":35},{"name":53,"role":54,"phone":23,"phoneExt":23,"email":23},"Saad A Moharam, MD","PRINCIPAL_INVESTIGATOR",{"type":54,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"Mohammed Said ElSharkawy","Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.","100579122",false,"NCT06820190","Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion","Comparison of Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion: A Randomized Clinical Trial","Inclusion Criteria:\n\n* Age ≥ 18 years.\n* Both sexes.\n* American Society of Anesthesiology (ASA) physical status I-II.\n* Idiopathic scoliosis patients undergoing posterior spinal fusion surgery.\n\nExclusion Criteria:\n\n* Patients with pre-existing infection at block site.\n* Known allergy to study drugs.\n* Coagulation disorder.\n* History of psychiatric illness.\n* Pre-existing neurological deficits.\n* Patient with morbid obesity (body mass index \\>40 kg\u002Fm2).\n* Presence of any pre-operative pain or history of chronic pain.\n* History of regular analgesic.","ALL","18 Years",{"count":67,"type":68},40,"ESTIMATED","INTERVENTIONAL",[71],"NA","This study aims to compare the analgesic efficacy of multiple mid-transverse process to pleura (MTP) block and PCA in idiopathic scoliosis patients undergoing posterior spinal fusion surgery.",[74,29,75,76],"Multiple Mid-Transverse Process to Pleura","Idiopathic Scoliosis","Posterior Spinal Fusion","2026-01-06",{"date":79,"type":80},"2026-01-07","ACTUAL",{"date":82,"type":80},"2025-02-12",{"date":84,"type":68},"2026-12-01",{"name":5,"class":6},1]